SCHEMBL6507219

SCHEMBL6507219

N#CCOc1cccc(-c2ccc(-n3cc(NC(N)=O)c(C(N)=O)n3)cc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.44
TP53 P04637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
IRAK4 Q9NWZ3 4/20 0.39
CTSA P10619 2/20 0.38
DHODH Q02127 1/20 0.37
STIM1 Q13586 1/20 0.37
ORAI1 Q96D31 1/20 0.37
IKBKB O14920 1/20 0.36
POLQ O75417 1/20 0.36
LMNA P02545 2/20 0.35
SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465874 0.93 ITK (0.44) ITKTP53KDM4EALDH1A1SMN1; SMN2
SCHEMBL6470662 0.91 ITK (0.45) ITKTP53KDM4EALDH1A1NPC1
SCHEMBL6507373 0.88 ITK (0.45) ITKIRAK4CTSADHODHIKBKB
SCHEMBL6465917 0.88 ITK (0.41) ITKIRAK4CTSADHODHPOLQ
SCHEMBL6499588 0.87 ITK (0.42) ITKKDM4ENPC1IRAK4IKBKB
SCHEMBL6471987 0.87 ITK (0.40) ITKIRAK4CTSAPOLQSCN9A
SCHEMBL6499891 0.87 ITK (0.46) ITKTP53KDM4EALDH1A1NPC1
SCHEMBL6499288 0.86 PLA2G10 (0.45) ITKTP53KDM4EALDH1A1NPC1
SCHEMBL6502983 0.86 ITK (0.41) ITKKDM4EALDH1A1NPC1MAPK1
SCHEMBL6470300 0.86 ITK (0.52) ITKTP53KDM4EALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885TP53 711/4885KDM4E 2424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.